Cancer Research UK's Commercial Partnerships team, a component of the Research and Innovation division, develops promising ideas into successful cancer therapeutics, vaccines, diagnostics and enabling technologies. We are dedicated to advancing discoveries to beat cancer by developing and commercialising exciting new discoveries in cancer research. Our deep understanding of both academia and industry enables us to translate promising research into commercial propositions to deliver patient benefit and commercial value that will support further cancer research.
Cancer Research UK, through its subsidiary Cancer Research Technology Ltd., has exclusive rights to more than £350m of world-class cancer research annually. As funders of much of the exciting science happening in the UK and beyond today, we offer unique opportunities to commercial partners looking for early involvement in new discoveries.